Serum CA 125, CA 15-3, CEA, and CA 19-9: a prognostic factor for uterine carcinosarcomas?

Nikolaos Thomakos; Alexandros Rodolakis; Flora Zagouri; Dimitrios Zacharakis; Maria Sotiropoulou; Nikolaos Akrivos; Dimitrios Haidopoulos; Christos Papadimitriou; Meletios A Dimopoulos; Aris Antsaklis

doi:10.1007/s00404-012-2529-6

Related publications

Article2003

Prognostic significance of CA 125, CD44, and epithelial membrane antigen in renal cell carcinoma

Aristotle Bamias, Maria Chorti, C. Deliveliotis, Νικόλαος Τράκας, Andreas Skolarikos, B. Protogerou, Stella Legaki, Georgia Tsakalou, N. Tamvakis, Meletios A Dimopoulos

Article2002

Serum, Pleural Effusion, and Ascites CA-125 Levels in Ovarian Cancer and Nonovarian Benign and Malignant Diseases: A Comparative Study

Patrick Neven, Steven R. Goldstein, A Ciaccia, Lifen Zhou, Sheryl L. Silfen, David Muram, Malene R. Andersen, Sarah Peacock, James H. Nelson, Sue Wilson, Martin McIntosh, Charles W. Drescher, Nicole Urban, J. Fiorica, R. Holloway, Boniface Ndubisi, J. W. Orr, Edward C. Grendys, Richard A. Boothby, Steven DeCesare, James P. LaPolla, Maureane Hoffman, Jaina M. Patel, Barbara Gawrońska‐Kozak, Carola Leuschner, Frederick M. Enright, William Hansel, Thierry Simonart, Johan R. Boelaert, Roger Mosselmans, Graciela Andreï, Jean‐Christophe Noël, De Clercq Erik,

Article2023

Prognostic and predictive significance of CA-125 elimination rate constant K (KELIM) in ovarian cancer patients treated with neoadjuvant chemotherapy in a real-world setting.

Michalis Liontos, Alkistis Papatheodoridi, Elena Kunadis, Anna Svarna, Charalampos Theofanakis, Oraianthi Fiste, Angeliki Rouvali, Kalliroi Goula, Christos Markellos, Angeliki Andrikopoulou, Eirini Potiri, Αριστέα-Μαρία Παπανώτα, Maria Kaparelou, Konstantinos Koutsoukos, Nikolaos Thomakos, Dimitrios Haidopoulos, Alexandros Rodolakis, Flora Zagouri, Benoît You, Meletios A Dimopoulos

Article2018

Management of uterine sarcomas and prognostic indicators: real world data from a single-institution

Anastasios Kyriazoglou, Michalis Liontos, Dimitrios C. Ziogas, Flora Zagouri, Kostantinos Koutsoukos, G. Tsironis, Anna Tsiara, Maria Kaparelou, Roubini Zakopoulou, Nikolaos Thomakos, Dimitrios Haidopoulos, Irene Papaspyrou, Alexandros Rodolakis, Aristotelis Bamias, Meletios A Dimopoulos

Article2011

645 SERUM CARBONIC ANHYDRASE 9 (CA) IS A VALUABLE BIOMARKER (BM) TO PROFILE PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC) TREATED WITH SORAFENIB AND PREDICT THEIR OUTCOME

María Reig, Loreto Boix, Alejandro Forner, Jordi Rimola, Carlos Rodríguez de Lope, J.M. López-Oliva, Silvia Tremosini, Neus Llarch, Josep M. Llovet, Carmen Ayuso, Jordi Bruix

Journal of Hepatology